Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

S H L Telemedicine Ltd receives the China Food and Drug Administration for marketing of smartheartTM in China

Wednesday, 14 May 2014 01:00am EDT 

S H L Telemedicine Ltd:Says it has received the China Food and Drug Administration (CFDA) approval for the marketing of the smartheartTM in China.The smartheartTM has already received marketing approvals in Europe, the U.S. and Japan. 

Company Quote

0.0 +0.00%
31 Jul 2014